Zobrazeno 1 - 8
of 8
pro vyhledávání: '"John A G Moir"'
Publikováno v:
Anti-Cancer Drugs. 31:737-741
Repurposing commonly prescribed noncancer medications for use in oncology has substantial advantages over de-novo development of anticancer drugs. Calcium signalling has been implicated in many of the hallmarks of cancer. Previous in-vitro and in-viv
Autor:
Emily R Thompson, John A G Moir, Samuel J Tingle, David Talbot, Ibrahim K Ibrahim, Colin H Wilson, Rodrigo Figueiredo, Lucy Bates, Michael Goodfellow
Publikováno v:
Clinical transplantationREFERENCES. 34(4)
Background There remains a lack of consensus on the optimal storage method for deceased donor kidneys. This meta-analysis compares storage with hypothermic machine perfusion (HMP) vs traditional static cold storage (SCS). Methods The Cochrane Kidney
Publikováno v:
Surgical Oncology. 24:232-238
Background The prognosis of pancreatic cancer remains desperately poor, with little progress made over the past 30 years despite the development of new combination chemotherapy regimens. Stromal activity is especially prominent in the tissue surround
Publikováno v:
British Journal of Surgery. 102:3-52
Publikováno v:
HPB. 18
Publikováno v:
Case Reports in Gastroenterology, Vol 4, Iss 2, Pp 267-272 (2010)
Case Reports in Gastroenterology
Case Reports in Gastroenterology
Meningiomas are slow-growing intracranial/intraspinal tumours, with a wide range of histopathological variants. The more aggressive atypical and malignant types can disseminate via the venous system, lymphatics or cerebrospinal fluid, with the lungs
Autor:
Derek Manas, Steven A. White, Jeremy French, F. Colgan, John A G Moir, J. Barnes, J. Burns, Peter Littler
Publikováno v:
The British journal of surgery. 102(12)
Background Selective internal radiation therapy (SIRT) is a non-ablative technique for the treatment of liver primaries and metastases, with the intention of reducing tumour bulk. This study aimed to determine optimal patient selection, and elucidate
Publikováno v:
The international journal of biochemistrycell biology. 57
The outcomes of pancreatic cancer remain dismal due to late clinical presentation and the aggressive nature of the disease. A heterogeneous combination of genetic mutations, including KRAS, INK4a/CDKN2A and p53, underpin the propensity of pancreatic